These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12916861)
1. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies. Galmarini CM; Jordheim L; Dumontet C Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861 [TBL] [Abstract][Full Text] [Related]
2. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II. Itoh R Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of cytosolic 5'-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine. Barsotti C; Pesi R; Giannecchini M; Ipata PL J Biol Chem; 2005 Apr; 280(14):13465-9. PubMed ID: 15699053 [TBL] [Abstract][Full Text] [Related]
5. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism. Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773 [TBL] [Abstract][Full Text] [Related]
15. Membrane-bound 5'-nucleotidase/nucleoside phosphotransferase from Bacillus cereus. Baiocchi C; Pesi R; Turriani M; Tozzi MG; Camici M; Ipata PL Int J Biochem; 1993 Nov; 25(11):1625-9. PubMed ID: 8288031 [TBL] [Abstract][Full Text] [Related]
16. Initial studies to define the physiologic role of cN-II. Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970 [TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of recombinant bovine cytosolic 5'-nucleotidase IMP-GMP specific. Allegrini S; Pesi R; Tozzi MG; Eriksson S Adv Exp Med Biol; 1998; 431():231-5. PubMed ID: 9598065 [No Abstract] [Full Text] [Related]
18. The enzymology of cytosolic pyrimidine 5'-nucleotidases: functional analysis and physiopathological implications. Magni G; Amici A; Orsomando G Curr Med Chem; 2013; 20(34):4304-16. PubMed ID: 23992312 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic perspectives for cN-II in cancer. Jordheim LP; Chaloin L Curr Med Chem; 2013; 20(34):4292-303. PubMed ID: 23992314 [TBL] [Abstract][Full Text] [Related]